MAQUET Medical Systems AG, registered office: Rastatt, Kehler Straße 31, 76437 Rastatt (AG Mannheim HRB 719044), an indirect subsidiary of Getinge AB, Sweden, submitted a request on 15 May 2025 to ...

Medical technology company Inspire Medical Systems (NYSE:INSP) announced better-than-expected revenue in Q1 CY2025, with sales up 22.7% year on year to $201.3 million. The company expects the full ...

So on that note, Merit Medical Systems (NASDAQ:MMSI) looks quite promising in regards to its trends of return on capital. AI is about to change healthcare. These 20 stocks are working on ...

In the preceding three months, 14 analysts have released ratings for Merit Medical Systems MMSI, presenting a wide array of perspectives from bullish to bearish. The following table summarizes ...

Inspire Medical Systems INSP underwent analysis by 13 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their ...

KORU Medical Systems reported a strong start to 2025 with its Q1 revenue of $9.6 million, exceeding forecasts by 9.3%. The company’s stock rose by 1.1% in aftermarket trading, reflecting ...

Inspire Medical Systems (INSP) reported its financial results for the first quarter of 2025, significantly exceeding earnings expectations with an EPS of $0.10, compared to a forecasted loss of -$ ...

Full Year Gross Margin Guidance: 84% to 86%. Inspire Medical Systems Inc (NYSE:INSP) achieved a significant milestone by surpassing 100,000 patients who have received Inspire therapy. The company ...

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and ...

Medical alert systems make accessing help in an emergency easy. Whether you fall and injure yourself or experience another type of medical situation, these systems can dispatch help from an ...

Inspire Medical Systems, Inc. (NYSE:INSP), a medical technology company focused on treating obstructive sleep apnea (OSA), presented its latest corporate overview on May 5, 2025, highlighting ...